| Literature DB >> 26476268 |
Alessio Cortelazzo1, Claudio De Felice2, Roberto Guerranti3, Cinzia Signorini4, Silvia Leoncini5, Alessandra Pecorelli5, Francesco Scalabrì6, Michele Madonna7, Stefania Filosa8, Cinzia Della Giovampaola9, Antonietta Capone9, Thierry Durand10, Cristiana Mirasole11, Lello Zolla11, Giuseppe Valacchi12, Lucia Ciccoli4, Jacky Guy13, Maurizio D'Esposito14, Joussef Hayek15.
Abstract
Neurological disorders can be associated with protein glycosylation abnormalities. Rett syndrome is a devastating genetic brain disorder, mainly caused by de novo loss-of-function mutations in the methyl-CpG binding protein 2 (MECP2) gene. Although its pathogenesis appears to be closely associated with a redox imbalance, no information on glycosylation is available. Glycoprotein detection strategies (i.e., lectin-blotting) were applied to identify target glycosylation changes in the whole brain of Mecp2 mutant murine models of the disease. Remarkable glycosylation pattern changes for a peculiar 50kDa protein, i.e., the N-linked brain nucleotide pyrophosphatase-5 were evidenced, with decreased N-glycosylation in the presymptomatic and symptomatic mutant mice. Glycosylation changes were rescued by selected brain Mecp2 reactivation. Our findings indicate that there is a causal link between the amount of Mecp2 and the N-glycosylation of NPP-5.Entities:
Keywords: Mecp2; Neurological disorders; Nucleotide pyrophosphatase; Protein glycosylation
Mesh:
Substances:
Year: 2015 PMID: 26476268 DOI: 10.1016/j.neures.2015.10.002
Source DB: PubMed Journal: Neurosci Res ISSN: 0168-0102 Impact factor: 3.304